The Chairman of the Pharmaceutical Authority discusses the sustainability of the pharmaceutical supply of the market with representatives of the drug distribution companies
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, held a meeting with representatives of the pharmaceutical distribution companies, in the context of the authority’s keenness to enhance cooperation with the relevant partners. The balance between the requirements of sustainable development and ensuring that medicines reach high quality and efficiency. Coordination and communication to keep pace with global changes, and achieve integration between pharmaceutical and economic policies, in a manner that ensures the best benefit to the health and pharmaceutical sector.
& nbsp; Osama Hatem, Associate Chairman of the Authority for International Cooperation, Supervisor of the Central Administration for Pharmaceutical Policies, Director General of the General Administration of International Cooperation, Dr. Hossam Abdullah, Deputy Chairman of the Authority for Support and Follow -up of Markets, Director General of the General Administration for Markets Support and Labor Continuity. The CEO of a private company, Dr. Omar Abdel -Gawad, Chairman of the Board of Directors of the company, Dr. William Mahni, Chairman of the Board of Directors of a private company, d. Mohamed Jalal, Vice -Chairman of the Pharmaceutical Company, d. Mohab Jazidin, Vice Chairman of the Medicines Company, d. Ahmed Mohab Jazarin, member of the company’s board of directors, d. Ahmed Saeed, the company’s commercial director.
